Insights, guides, and updates on clinical trials, research technology, and regulatory compliance.
Apps might get more attention, but SMS still delivers. In digital trials, a simple text message can be the link that keeps participants engaged and on track.
Audit trails should not be noise. They should tell a clear story of what happened, when, and why. In digital trials, they are how the study proves it was run with care.
Recruitment materials have got noticeably better at inclusive language. Consent forms, the document participants actually sign, are lagging behind.
The MHRA isn't banning AI from inspection responses. It is making it very clear who is accountable when an AI-assisted response turns out to be wrong.
Long-term studies aren't won at sign-up. They're won in the quiet weeks when life gets busy, motivation dips and thoughtful design keeps participants going.
Digital trials shift the workload, but they don't remove it. Study sites still carry the weight, and how we support them makes all the difference.
Smart systems catch missing fields. But they don't catch subtle contradictions or behavioural patterns. That still takes human eyes and clinical judgement.
Participant Information Sheets are one of the first touchpoints in a study. If they confuse or overwhelm, trust is lost before the first task even begins.
Monitoring does not disappear in decentralised trials. It evolves. Less about binders, more about patterns, systems and conversations that still matter.
